Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein L9 expression

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3874-3884

  Kreit, Marguerite ^a   Paul, Sophie ^a,c   Knoops, Laurent ^a,b   De Cock, Aurélie ^a   Sorgeloos, Frédéric ^a   Michielsa, Thomas ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c Cardio3 BioSciences   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN; APOLIPOPROTEIN L9B; BETA INTERFERON; CELL PROTEIN; PROTEIN MX1; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOLIPOPROTEIN L9B GENE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; INFECTION RESISTANCE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAT1 GENE; VIRUS REPLICATION;

ANIMALS; APOLIPOPROTEINS; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; INTERFERON TYPE I; MICE; NEURONS; THEILOVIRUS; VESICULOVIRUS;

EID: 84895487764     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03018-13     Document Type: Article

References (47)

1. Griffin DE, Metcalf T. 2011. Clearance of virus infection from the CNS. Curr. Opin. Virol. 1:216-221. http://dx.doi.org/10.1016/j.coviro.2011.05 .021.
2. Paul S, Ricour C, Sommereyns C, Sorgeloos F, Michiels T. 2007. Type I interferon response in the central nervous system. Biochimie 89:770-778. http://dx.doi.org/10.1016/j.biochi.2007.02.009.
3. Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T. 2013. Antiviral type I and type III interferon responses in the central nervous system. Viruses 5:834-857. http://dx.doi.org/10.3390/v5030834.
4. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Senechal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Heron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-312. http://dx.doi .org/10.1126/science.1128346.
5. Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. 2011. Inborn errors of anti-viral interferon immunity in humans. Curr. Opin. Virol. 1:487-496. http://dx.doi.org/10.1016/j.coviro.2011.10 .016.
6. Daffis S, Samuel MA, Suthar MS, Gale M, Jr, Diamond MS. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82:10349-10358. http://dx.doi.org/10.1128/JVI.00935-08.
7. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103:7835-7840. http://dx.doi.org/10.1073 /pnas.0602460103.
8. Préhaud C, Megret F, Lafage M, Lafon M. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79:12893-12904. http://dx.doi.org/10.1128/JVI.79.20 .12893-12904.2005.
9. Wang J, Campbell IL. 2005. Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon. J. Virol. 79:8295-8302. http://dx.doi.org/10.1128/JVI.79.13.8295-8302.2005.
10. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BR, Silverman RH, Gale M, Jr, Diamond MS. 2006. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80:7009-7019. http://dx.doi.org/10.1128/JVI.00489-06.
11. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of la crosse virus-infected mice. J. Virol. 86:11223-11230. http://dx.doi.org/10.1128/JVI.01093-12.
12. Lin CC, Wu YJ, Heimrich B, Schwemmle M. 2013. Absence of a robust innate immune response in rat neurons facilitates persistent infection of Borna disease virus in neuronal tissue. Cell. Mol. Life Sci. 70:4399-4410. http://dx.doi.org/10.1007/s00018-013-1402-5.
13. Staeheli P, Sentandreu M, Pagenstecher A, Hausmann J. 2001. Alpha/ beta interferon promotes transcription and inhibits replication of Borna disease virus in persistently infected cells. J. Virol. 75:8216-8223. http: //dx.doi.org/10.1128/JVI.75.17.8216-8223.2001.
14. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Jr, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat. Med. 19:458-464. http://dx.doi.org/10.1038 /nm.3108.
15. Horisberger MA, Staeheli P, Haller O. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. U. S. A. 80:1910-1914. http://dx.doi.org/10.1073 /pnas.80.7.1910.
16. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. 2001. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111-1116. http://dx.doi.org/10 .1038/35074129.
17. Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD, Price RE, Hittelman WN, Wistuba II, Kurie JM. 2005. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res. 65:3226-3235. http://dx.doi.org /10.1158/0008-5472.CAN-04-4420.
18. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
19. Banker GA, Cowan WM. 1977. Rat hippocampal neurons in dispersed cell culture. Brain Res. 126:397-425. http://dx.doi.org/10.1016/0006-8993(77)90594-7.
20. Fath T, Ke YD, Gunning P, Gotz J, Ittner LM. 2009. Primary support cultures of hippocampal and substantia nigra neurons. Nat. Protoc. 4:78-85. http://dx.doi.org/10.1038/nprot.2008.199.
21. Hermant P, Francius C, Clotman F, Michiels T. 2013. IFN-e is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines. PLoS One 8:e71320. http://dx.doi.org /10.1371/journal.pone.0071320.
22. van Pesch V, Lanaya H, Renauld JC, Michiels T. 2004. Characterization of the murine alpha interferon gene family. J. Virol. 78:8219-8228. http: //dx.doi.org/10.1128/JVI.78.15.8219-8228.2004.
23. van Pesch V, Michiels T. 2003. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J. Biol. Chem. 278: 46321-46328. http://dx.doi.org/10.1074/jbc.M302554200.
24. Daniels JB, Pappenheimer AM, Richardson S. 1952. Observations on encephalomyelitis of mice (DA strain). J. Exp. Med. 96:517-530. http://dx .doi.org/10.1084/jem.96.6.517.
25. Theiler M, Gard S. 1940. Encephalomyelitis of mice. I. Characteristics and pathogenesis of the virus. J. Exp. Med. 72:49-67.
26. Michiels T, Dejong V, Rodrigus R, Shaw-Jackson C. 1997. Protein 2A is not required for Theiler's virus replication. J. Virol. 71:9549-9556.
27. Tangy F, McAllister A, Brahic M. 1989. Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J. Virol. 63:1101-1106.
28. van Pesch V, van Eyll O, Michiels T. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-7817. http://dx.doi.org/10.1128/JVI.75.17.7811-7817.2001.
29. Jnaoui K, Michiels T. 1998. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence. Virology 244:397-404. http://dx.doi.org/10.1006/viro.1998.9134.
30. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:217-222. http://dx.doi.org /10.1038/76095.
31. Shaw-Jackson C, Michiels T. 1999. Absence of internal ribosome entry site-mediated tissue specificity in the translation of a bicistronic transgene. J. Virol. 73:2729-2738.
32. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. 2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283-1298. http://dx.doi.org/10.1016/j.cell.2006.01.040.
33. Paul S, Michiels T. 2006. Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J. Gen. Virol. 87:1237-1246. http://dx.doi.org/10.1099/vir.0.81642-0.
34. Meier E, Fah J, Grob MS, End R, Staeheli P, Haller O. 1988. A family ofinterferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J. Virol. 62:2386-2393.
35. Burdeinick-Kerr R, Griffin DE. 2005. Gamma interferon-dependent, noncytolytic clearance of Sindbis virus infection from neurons in vitro. J. Virol. 79:5374-5385. http://dx.doi.org/10.1128/JVI.79.9.5374-5385.2005.
36. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79:4460-4469. http://dx.doi.org/10.1128/JVI.79.7 .4460-4469.2005.
37. Oliver KR, Scallan MF, Dyson H, Fazakerley JK. 1997. Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. J. Neurovirol. 3:38-48. http://dx.doi.org/10 .3109/13550289709015791.
38. Labrada L, Liang XH, Zheng W, Johnston C, Levine B. 2002. Agedependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 76:11688-11703. http://dx.doi.org/10.1128/JVI.76.22.11688-11703.2002.
39. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10 .1038/nature09907.
40. Adler M, Tavalai N, Muller R, Stamminger T. 2011. Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J. Gen. Virol. 92:1532-1538. http://dx.doi.org /10.1099/vir.0.030981-0.
41. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O. 2010. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. U. S. A. 107:1512-1517. http://dx.doi.org/10.1073/pnas .0912986107.
42. Katsoulidis E, Carayol N, Woodard J, Konieczna I, Majchrzak-Kita B, Jordan A, Sassano A, Eklund EA, Fish EN, Platanias LC. 2009. Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses. J. Biol. Chem. 284:25051-25064. http://dx.doi.org /10.1074/jbc.M109.030445.
43. Choubey D, Duan X, Dickerson E, Ponomareva L, Panchanathan R, Shen H, Srivastava R. 2010. Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J. Interferon Cytokine Res. 30:371-380. http://dx.doi.org/10.1089/jir .2009.0096.
44. Smith EE, Malik HS. 2009. The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res. 19:850-858. http://dx.doi .org/10.1101/gr.085647.108.
45. Vanhollebeke B, Nielsen MJ, Watanabe Y, Truc P, Vanhamme L, Nakajima K, Moestrup SK, Pays E. 2007. Distinct roles of haptoglobinrelated protein and apolipoprotein L-I in trypanolysis by human serum. Proc. Natl. Acad. Sci. U. S. A. 104:4118-4123. http://dx.doi.org/10.1073 /pnas.0609902104.
46. Liu Z, Lu H, Jiang Z, Pastuszyn A, Hu CA. 2005. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol. Cancer Res. 3:21-31.
47. Zhaorigetu S, Yang Z, Toma I, McCaffrey TA, Hu CA. 2011. Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells. J. Biol. Chem. 286:27389-27398. http://dx.doi.org/10.1074/jbc.M110.210245.